GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Net Income

Sensus Healthcare (Sensus Healthcare) Net Income : $0.49 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Sensus Healthcare's Net Income for the three months ended in Dec. 2023 was $4.21 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was $0.49 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Sensus Healthcare's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.26.


Sensus Healthcare Net Income Historical Data

The historical data trend for Sensus Healthcare's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare Net Income Chart

Sensus Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.70 -6.84 4.12 24.24 0.49

Sensus Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.83 -1.89 -0.38 -1.45 4.21

Sensus Healthcare Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Sensus Healthcare's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

Net Income(A: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=0.652+-0.167+0+0
=0.49

Sensus Healthcare's Net Income for the quarter that ended in Dec. 2023 is calculated as

Net Income(Q: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=5.805+-1.595+0+0
=4.21

Net Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sensus Healthcare  (NAS:SRTS) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Sensus Healthcare's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Sensus Healthcare Net Income Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sensus Healthcare (Sensus Healthcare) Business Description

Traded in Other Exchanges
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Executives
Joseph C Sardano director, officer: Chief Executive Officer 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano officer: GENERAL COUNSEL 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
John Heinrich director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall director 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla officer: Chief Financial Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish director 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman officer: CHIEF TECHNOLOGY OFFICER 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487